What our research found
Try Ageless is a consumer telehealth platform, not the treating medical practice or dispensing pharmacy. The current medical-oversight page says Lovely Meds, Inc. operates the platform, Wasef Health, PC provides clinical care, and Pharmacy Hub dispenses prescriptions. The latest terms and privacy policy instead call Try Ageless a brand of Lovely Ageless Group, without reconciling the entity names.
The oversight page names Michael Wasef, MD, NPI 1417261926. The federal NPPES registry returns an active exact-number record with Internal Medicine as the primary taxonomy and Florida license ME125730. The record verifies the published identity, but it does not establish that Dr. Wasef personally reviews every intake.
Pharmacy Hub is also independently verifiable. Federal NPPES records show an active organization at the Miami address published by Try Ageless. The Florida Department of Health lists The Pharmacy Hub LLC under permit PH33959 with clear status, the same address, and no discipline on file in the current record. License status is not approval of every compounded prescription.
The standard flow begins with an online questionnaire, identity and health information, product selection, and payment details. A licensed clinician can review asynchronously or request a phone or video visit, additional information, testing, or in-person care. A prescription is never guaranteed.
The weight-loss plan table lists semaglutide plus B12 injection at $175 for one month, $435 for three months, $720 for six months, or $1,188 for twelve months. Those effective rates are $175, $145, $120, and $99. Their unweighted mean is $134.75, displayed as Avg. $135/mo. Longer terms require prepayment.
Tirzepatide plus B12 injection is $235 for one month, $597 for three months, $1,050 for six months, or $1,800 for twelve months. The effective rates of $235, $199, $175, and $150 average to $189.75, displayed as Avg. $190/mo. Supplies and shipping are described as included.
Neither injection program is attached to the plain semaglutide or tirzepatide catalog record. Both current product names explicitly include B12, which makes them compounded combinations rather than exact single-ingredient matches. The averages remain useful service prices, but they do not become medication-comparison cards.
Tirzepatide sublingual drops demonstrate why a page-level check matters. The plan table lists $199 for one month, $549 for three, $1,074 for six, and $1,908 for twelve, which would average to $180 per month. The separate product page shows $249 per month. The review withholds a compact price until Try Ageless reconciles the current pages.
The semaglutide injection product page also uses a $99 headline while deeper copy publishes a $119 to $229 range and says price varies by dose. The four-term weight-loss table is used for the plan reconstruction because it maps complete totals to term lengths, while the dose-dependent product-page conflict stays disclosed.
The testosterone injection and topical pages each advertise $129 per month. The injection page offers cypionate or enanthate and several carrier-oil or commercial options, so one price cannot be assigned to a single ester without knowing the prescription. Baseline and ongoing laboratory testing are required, and no universal included laboratory fee is public.
KYZATREX is an FDA-approved oral testosterone undecanoate product listed at $209 per month. Try Ageless says treatment requires two morning testosterone tests plus ongoing monitoring and that the final price can depend on dose. A separate generic oral-testosterone page lists $129 monthly without clearly identifying the exact product or formulation.
The enclomiphene page advertises $119 per month and laboratory monitoring, but official product material alternates among tablet, capsule, and topical route labels. hCG is shown as a 10,000 IU add-on at $209 per month rather than a standalone program. Neither becomes a new normalized card.
The longevity catalog includes NAD+ and sermorelin in several routes. The exact NAD+ 1,000 mg injection product is $199 per month and maps to the existing compounded injection record, although concentration, vial quantity, schedule, and included supplies still require confirmation. NAD+ troches are route variants, not another medication.
Sermorelin injection maps to the existing compounded injection record but does not receive a compact price. A current headline says $126 per month while deeper product detail shows $239 to $289. Troche and nasal-spray products remain route variants, and the nasal page incorrectly labels the route as sublingual in one field.
Olympus Max Male Troche is a $149 compounded combination of oxytocin 40 IU, bremelanotide 2 mg, and tadalafil 20 mg. It remains editorial-only because the branded formula is not an exact reusable catalog combination. Calling it simply tadalafil would conceal two active ingredients and overstate comparability.
Current terms say controlled substances are never prescribed through the service. That statement conflicts directly with the testosterone catalog and the KYZATREX page, which identifies the product as Schedule III. Patients should obtain the exact prescription, prescriber, pharmacy, monitoring plan, and legal availability for their location before relying on the general terms.
Compounded semaglutide, tirzepatide, NAD+, sermorelin, testosterone, and combination formulas are not FDA approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. FDA also currently says semaglutide and tirzepatide are not on the shortage list and explains that routine essentially-copy compounding is restricted outside specific legal conditions.
FDA issued a warning letter to Lovely Meds, Inc. doing business as Lovely Meds about claims on lovelymeds.com that implied compounded semaglutide and tirzepatide were the same as FDA-approved products. The letter did not name tryageless.com or evaluate this review. The connection is disclosed because Try Ageless currently says Lovely Meds, Inc. operates its platform.
The latest dated terms say future renewals can be cancelled through the portal where available or by email before the charge and before an order enters review or fulfillment. Cancellation affects future renewals only. Once pharmacy processing begins, prescription medication is generally nonrefundable and cannot be returned or restocked.
A $55 TRT consultation fee or $40 non-TRT consultation fee can be deducted after review begins or completes, including a clinician decline or missed appointment. The current terms also permit a 2.9 to 4.9 percent payment-processing deduction, removal of promotional pricing, repricing of an early-cancelled prepaid plan to a shorter term, and deductions for shipping, laboratory, pharmacy, or other committed costs.
The older refund page does not match the latest terms. It describes one $40 administrative or clinical fee, a 10 percent deduction from a remaining prepaid balance, and a fifteen-business-day refund timeline. The latest terms use different amounts and say approved refunds are generally initiated within ten business days, so the latest terms control for this review.
Several treatment pages advertise a 30-day money-back or satisfaction guarantee and mention refunds on unopened medication. Those statements are not reconciled with the latest terms or older refund page, both of which generally prohibit prescription returns once processing or dispensing begins. Do not assume the marketing guarantee overrides the operative checkout terms.
Try Ageless is cash pay. Current terms say the service does not bill commercial insurance, Medicare, or Medicaid. The testosterone injection page says HSA or FSA eligible, but that treatment-specific provider statement does not guarantee reimbursement for every product or card administrator.
Treatment pages advertise included standard shipping, discreet outer packaging, tracking after dispatch, and typical arrival in three to five business days after approval. The general FAQ uses a less specific timeline tied to location, clinical review, pharmacy processing, and carrier conditions. Temperature-control packaging may apply to some products.
The site describes service for adults age 18 or older in eligible U.S. locations but does not publish one complete current state list for every product. Treatment availability depends on clinician licensure, prescribing rules, pharmacy service, product route, and delivery location.
Public support routes include email, chat or contact form, the patient portal, and clinical messaging. The contact page lists (310) 361-7849, while the medical-oversight page lists +1 (302) 440-4386. No current support hours, response-time commitment, or universal emergency channel is published.
The Katalys application is pending under offer 1538 with recorded payouts of $300 for an approved weight-loss sale and $160 for an approved longevity or TRT sale. Discovery EPC was $0.32, no tracking URL has been issued, and no public coupon has been verified as affiliate compatible. Commercial terms affected queue order only, not the score or conclusions.
- Four GLP-1 terms reconstruct to Avg. $135/mo for semaglutide plus B12 and Avg. $190/mo for tirzepatide plus B12.
- The named physician and pharmacy identities and Florida license records are independently verifiable.
- The current operator name and several product, route, refund, and controlled-substance statements conflict across official pages.
- The FDA warning letter concerned Lovely Meds and lovelymeds.com, not the Try Ageless domain, but the current operator disclosure makes the relationship relevant.